Skip to main content
Fig. 5 | Cancer Cell International

Fig. 5

From: Carboxypeptidase N1 is anticipated to be a synergy metrics for chemotherapy effectiveness and prognostic significance in invasive breast cancer

Fig. 5

Representative patient cases. Patient025, a 53-year-old woman who diagnosed as TNBC and met PR criteria in cycle4. Patient028, a 53-year-old woman who diagnosed as HER2-positive breast cancer pathologically and met PR criteria in cycle4. A, B, a, b Left breast swelling, C, D, c, d Axillary lymph nodes; E, e Levels of CPN1 and tumor burden in Cycle3 and Cycle4

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us